NicOx On Track For First-Quarter 2009 Naproxcinod Filing
French firm aims to become a fully integrated biopharma within three years, with commercial operations in the U.S. and major EU countries.
French firm aims to become a fully integrated biopharma within three years, with commercial operations in the U.S. and major EU countries.